Chlamydia trachomatis serovars DK are one of the most frequent causes of sexually
transmitted infections of the female genital tract, with possible complications such as …

Citation Cunningham KA, Carey AJ, Hafner L, Timms P, Beagley KW. Chlamydia muridarum
major outer membrane protein‐specific antibodies inhibit in vitro infection but enhance …

The ability to induce protection against a genital challenge was studied in BALB/c female
mice with three Chlamydia trachomatis mouse pneumonitis (MoPn) major outer membrane …

Intrauterine infection of mice with a human genital tract isolate of Chlamydia trachomatis
(serovar F) resulted in salpingitis. In some cases, oviduct damage was sufficient to cause …

Previously we reported that recombinant Chlamydia muridarum macrophage infectivity
potentiator (MIP) provided partial protection against C. muridarum genital tract infection in …

Chlamydia trachomatis sexually transmitted infections cause considerable morbidity and
socioeconomic burden worldwide, despite significant advances in our understanding of the …

Chlamydia trachomatis infections in women are often asymptomatic and if left untreated can
lead to significant late sequelae including pelvic inflammatory disease and tubal factor …

Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) for which a
vaccine is needed. CD4+ T-helper type 1 (Th1) cell-mediated immunity is an important …

Despite effective antimicrobial chemotherapy, control of Chlamydia trachomatis urogenital
infection will likely require a vaccine. We have assessed the protective effect of an outer …

A vaccine formulated with the Chlamydia muridarum recombinant major outer membrane
protein, plus the adjuvants CpG and Montanide, was tested for its ability to protect BALB/c …